SYNTHESIS AND SPECTROSCOPIC STUDIES OF Mn(II), Co(II), AND Cu(II) COMPLEXES
601
(a)
(b)
Fig. 9. 3D structures of (a) II and (b) III complexes.
Mosaddik, M.A., and Alam, M.S., J. Biol. Sci., 2002,
vol. 2(12), p. 797.
Staphylococcus aureus. All new substances have also
been evaluated for their antifungal activity. The minimal
inhibitory concentration values listed in Table 6 show
that all tested compounds have no effect on Aspergillus
flavus, but have high effect on Candida albicans.
10. Ferrari, M.B., Capacchi, S., Pelosi, G., Reffo, G.,
Tarasconi, P., Albertini, R., Pinelli, S., and Lunghi, P.,
Inorg. Chim. Acta, 1999, vol. 286(2), p. 134.
11. Chohan, Z.H., Pervez, H., Khan, K.M., Rauf, A., and
Supuran, C.T., J. Enzyme Inhib. Med. Chem., 2004,
vol. 19(1), p. 51.
12. Canpolat, E. and Kaya, M., J. Coord. Chem., 2004,
vol. 57(14), p. 1217.
13. Refat, M.S., J. Mol. Struct., 2013, vol. 1037, p. 170.
14. Barnum, W., J. Inorg. Nucl. Chem., 1961, vol. 21, p. 221.
15. Holm, R.H. and Cotton, F.A., J. Am. Chem. Soc., 1958,
vol. 80, p. 5658.
16. Cotton, F.A. and Wilkinson, C.W., Advanced
Inorganic Chemistry, 3rd ed, New York: Interscience
Publishers, 1972.
17. Roy, R., Saha, M.C., and Roy, P.S., Trans. Met. Chem.,
1990, vol. 51, p. 5110.
18. Corbi, P.P., Cagnin, F., Sabeh, L.P.B., Massabni, A.C.,
and Costa-Neto, C.M., Spectrochim. Acta part A, 2007,
vol. 66, p. 1171.
19. Freeman E.S. and Carroll, B., J. Phys. Chem., 1958,
vol. 62, p. 394.
20. Sestak, J., Satava, V., and Wendlandt, W.W.,
Thermochim. Acta, 1973, vol. 7, p. 333.
21. Coats, A.W. and Redfern, J.P., Nature, 1964, vol. 201,
p. 68.
22. Ozawa, T., Bull. Chem. Soc. Jpn., 1965, vol. 38, p. 1881.
23. Wendlandt, W.W., Thermal Methods of Analysis, New
York: Wiley, 1974.
24. Horowitz, H.W. and Metzger, G., Anal. Chem., 1963,
vol. 35, p. 1464.
25. Flynn, J.H. and Wall, L.A., Polym. Lett., 1966, vol. 4, p. 323.
26. Kofstad, P., Nature, 1957, vol. 179, p. 1362.
Structure of the H2L1 and H2L2 and their
complexes. The fact that these compounds were
isolated as powders and not as single crystals means
that no complete structure determination (XRD) could
be made. Accordingly, using elemental analysis, molar
conductance, (infrared, 1H NMR, and mass) spectra as
well as thermogravimetric analysis; the suggested
structures of ligands II and III and their complexes
can be represented in Figs. 8–9.
REFERENCES
1. Chohan, Z.H., Farooq, M.A., Scozzafava, A., and
Supuran, C.T., J. Enzyme Inhib. Med. Chem., 2002,
vol. 17(1), p. 1.
2. Singh, K., Barwa, M.S., and Tyagi, P., Eur. J. Med.
Chem., 2006, vol. 41(1), p. 147.
3. Singh, K., Singh, D.P., Barwa, M.S., Tyagi, P., and
Mirza, Y., J. Enzym. Inhib. Med. Chem., 2006, vol. 21(5),
p. 557.
4. Cozzi, P.G., Chem. Soc. Rev., 2004, vol. 33, p. 410.
5. Jarrahpour, A.A. and Zarei, M., Molbank, 2004, p. M377.
6. Chandra, S. and Sangeetika, J., J. Indian Chem. Soc.,
2004, vol. 81, p. 203.
7. More, P.G. and Bhalvankar, R.B., J. Indian Chem. Soc.,
2004, vol. 81, p. 13.
8. Yildiz, M., Dulger, B., Koyuncu, S.Y., and Yapici, B.M.,
J. Indian Chem. Soc., 2004, vol. 81, p. 7.
9. Islam, M.S., Farooque, M.A., Bodruddoza, M.A.K.,
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 84 No. 3 2014